DIACOMIT (stiripentol)


SELF ADMINISTRATION- ORAL 


Indications for Prior Authorization:
  • Treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking Clobazam and Valproic acid.  There are no clinical data to support the use of Diacomit as monotherapy in Dravet syndrome.

Patients must meet the following criteria for the indications(s) above:
  • Dravet Syndrome:
    • Patient is 2 years of age or older, AND
    • Prescribed by or in consultation with a neurologist, AND
    • Diagnosis of Dravet syndrome confirmed by chart note documentation, AND
    • Patient has tried and failed Valproate, AND
    • The patient is concomitantly taking Clobazam OR the patient is unable to take Clobazam due to adverse events as determined by the prescribing physician (if unable to take with clobazam then the patient will be taking concomitantly with at least one other antiepileptic drug)
  • Treatment-refractory seizures/epilepsy, including Lennox-Gastaut Syndrome:
    • Patient is 2 years of age or older, AND
    • Prescribed by or in consultation with a neurologist, AND
    • Diagnosis of seizures confirmed by chart note documentation, AND
    • Patient has tried at least two other antiepileptic drugs (e.g., valproic acid, lamotrigine, topiramate, clonazepam, Banzel, felbamate, clobazam, Fycompa, Sabril, levetiracetam, zonisamide, etc.)
Dosing:
  • 50 mg/kg/day in 2 or 3 divided doses (maximum recommended total dosage is 3,000mg/day)
Approval:
  • 1 year

Last review date: July 16, 2019

Rite Aid Pharmacy Patients: All Rite Aid pharmacies nationwide are closing! Please be on the lookout for information from Rite Aid pharmacies about their bankruptcy and store closures. Call your Rite Aid pharmacy for questions about your prescriptions and new pharmacy options. WHA is here to help as well. Contact Us via Phone